Understanding Ocular Migraine
The term 'ocular migraine' is commonly used by patients and some doctors, but it does not appear in the International Classification of Headache Disorders (ICHD). Medical professionals use more specific terms to describe what most people call an ocular migraine. These include 'migraine with visual aura' and 'retinal migraine,' each referring to a different type of visual disturbance.
The distinction matters because migraine with visual aura affects both eyes at the same time, while retinal migraine affects only one eye. A retina specialist can help determine which type you are experiencing and whether further testing is needed.
Migraine with visual aura is the more common form. It causes visual disturbances in both eyes at the same time, such as shimmering zig-zag lines, kaleidoscope-like patterns, or expanding blind spots. These symptoms happen because of changes in electrical activity in the brain, not in the eye itself. They typically last 10 to 30 minutes and are often followed by a headache.
Retinal migraine is a less common and more concerning condition. It causes temporary vision loss or visual disturbances in only one eye. Symptoms can include a blind spot (scotoma), scintillating patterns, or even complete but temporary blindness in the affected eye. The headache phase usually begins within 60 minutes of the visual symptoms. Because retinal migraine involves the blood supply to the retina, it should be evaluated by a retina specialist to rule out other causes of monocular vision loss.
Who Is Affected and Risk Factors
Migraine is the third most prevalent illness in the world, affecting roughly 12% of the population (Migraine Research Foundation). It has a lifetime prevalence of about 43% for women and 18% for men (Modern Retina). In a large screening study of over one million patient charts, ocular migraine was identified in about 0.57% of individuals (ARVO, IOVS Journal).
Ocular migraine can begin as early as age 7, but most people first experience episodes in their 20s. The peak age for ocular migraine is around 40. Women are affected more often than men, which is consistent with the overall pattern of migraine. Approximately 28 million women in the United States experience migraine at some point in their lives (Modern Retina).
Researchers believe there is a strong genetic component to ocular migraines. About 50% of people who experience them have a close family member with a history of migraine headaches. If one or both of your parents had migraines, you are more likely to have them as well.
Ocular migraines share many triggers with other types of migraine. Identifying your personal triggers can help reduce how often episodes occur. Common triggers include:
- Emotional stress
- High blood pressure (hypertension)
- Hormonal changes, including menstrual cycles, menopause, or use of hormonal birth control pills
- Dehydration
- Low blood sugar (hypoglycemia)
- Intense exercise or physical exertion
- Being at a high altitude
- Smoking
- Overheating (hyperthermia)
Signs and Symptoms
The hallmark of an ocular migraine is a temporary visual disturbance. These visual symptoms typically last between 5 and 60 minutes before vision gradually returns to normal. The specific type of visual change depends on whether you are having a migraine with visual aura or a retinal migraine.
In migraine with visual aura, you may see shimmering or flickering lights, zig-zag patterns, or a slowly expanding blind spot. These changes appear in both eyes because they originate in the brain. In retinal migraine, the disturbance occurs in only one eye and may include a partial or complete loss of vision.
Many people experience a headache that follows the visual symptoms. The headache can begin within 60 minutes of when the visual disturbance starts. Without treatment, the headache phase can last from 4 to 72 hours. However, some people experience the visual symptoms without any headache at all. This is sometimes called a 'silent migraine.'
One of the most important things to notice during an ocular migraine is whether the visual change affects one eye or both. A simple way to check is to cover one eye at a time. If the visual disturbance is present in both eyes, it is likely a migraine with visual aura. If it affects only one eye, it may be a retinal migraine, which warrants a more thorough evaluation.
Diagnosis and Testing
Many conditions can cause temporary visual changes, and not all of them are migraines. A transient ischemic attack (a temporary interruption of blood flow to the brain, sometimes called a mini-stroke), retinal artery occlusion, or other vascular events can mimic the symptoms of an ocular migraine. Getting the right diagnosis is essential for receiving appropriate treatment and preventing more serious problems.
A retina specialist will perform a comprehensive dilated eye exam to look at the blood vessels and structures inside your eye. During an active retinal migraine, a doctor may observe reduced blood flow to the retina on fundoscopy (an examination of the back of the eye). Additional tests may include optical coherence tomography (OCT), which creates detailed cross-section images of the retina, and fluorescein angiography, which uses a special dye to photograph blood flow in the retinal vessels.
Because monocular vision loss (vision loss in one eye) can be a sign of a stroke or other vascular emergency, your retina specialist may coordinate with a neurologist or primary care doctor. Blood pressure readings, blood tests, and imaging of the brain or blood vessels may be recommended. This is especially important if your symptoms last longer than 60 minutes, occur for the first time later in life, or are accompanied by other neurological changes.
Treatment Options
The goal of acute treatment is to shorten the duration and severity of symptoms. Treatment should begin as early as possible during an attack for the best results. First-line treatment typically starts with nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, naproxen sodium, or diclofenac potassium. If NSAIDs alone are not adequate, a triptan medication may be added. Triptans are a class of medications approved by the FDA specifically for treating acute migraine episodes with or without aura. Seven triptans are available in the United States, including sumatriptan, naratriptan, zolmitriptan, rizatriptan, almotriptan, frovatriptan, and eletriptan.
Recent FDA approvals have expanded treatment options for people with migraine. Zavegepant (Zavzpret), a calcitonin gene-related peptide (CGRP) receptor antagonist, has been approved for the acute treatment of migraine. CGRP is a protein involved in pain signaling during migraine attacks, and blocking it can relieve headache and other symptoms. The FDA also granted approval to dihydroergotamine (DHE) nasal powder (Atzumi) and AXS-07 (Symbravo), an oral multi-mechanism agent, both for the acute treatment of migraine with or without aura.
Sporadic case reports have suggested that topical beta blocker eye drops may provide relief during acute migraine episodes. Beta blocker eye drops can reach therapeutic blood levels within minutes of being applied to the eye. While this is a promising area, it is not yet an established standard treatment. A retina specialist or neurologist can discuss whether this approach may be appropriate.
For people who experience frequent ocular migraines, prevention is a key part of management. Preventive strategies focus on avoiding known triggers and may include lifestyle changes. Staying well hydrated, managing stress, maintaining steady blood sugar levels, and monitoring blood pressure are all important steps. For some patients, a doctor may recommend daily preventive medication, especially if episodes are frequent or disabling.
What to Expect
Most ocular migraine episodes resolve within 10 to 20 minutes, though visual symptoms can last up to 60 minutes. Vision gradually returns to normal as blood flow to the retina or brain normalizes. During the episode, it is best to stop what you are doing, rest in a quiet and dimly lit room, and avoid driving or operating machinery until your vision fully returns.
Once the visual disturbance passes, you may develop a headache. The headache can range from mild to severe and may be accompanied by nausea, sensitivity to light, or sensitivity to sound. Taking medication early in the headache phase tends to be more effective than waiting for the pain to become severe.
For most people, ocular migraines do not cause permanent vision damage. However, retinal migraine specifically involves the blood supply to the retina, and repeated episodes of reduced blood flow raise concern. In rare cases, retinal migraine has been associated with lasting visual field loss. This is one reason why ongoing monitoring by a retina specialist is recommended if you have been diagnosed with retinal migraine.
Living With Ocular Migraine
Keeping a migraine diary can help you identify patterns and triggers. Record the date, time, duration of visual symptoms, which eye was affected, what you were doing before the episode, and any potential triggers such as stress, dehydration, or hormonal changes. This information is valuable for your retina specialist and any other doctors involved in your care.
Small changes in daily habits can reduce how often ocular migraines occur. Consider the following approaches:
- Drink enough water throughout the day to stay hydrated
- Eat regular meals to keep blood sugar stable
- Get consistent, adequate sleep each night
- Practice stress reduction techniques such as deep breathing or meditation
- Avoid known personal triggers when possible
Ocular migraine management often involves more than one type of doctor. A retina specialist evaluates the health of your retina and rules out other eye conditions. A neurologist may manage the migraine itself, especially if episodes are frequent or severe. Your primary care doctor can help with blood pressure management and overall health. Communication among these providers leads to better outcomes.
When to See a Retina Specialist
Certain visual symptoms should never be ignored. Seek evaluation from a retina specialist or go to the emergency room immediately if you experience any of the following:
- Sudden vision loss in one eye
- Visual symptoms that last longer than 60 minutes
- A new onset of visual disturbances you have never had before
- A sudden increase in floaters or flashes of light
- A shadow or curtain spreading across your field of vision
These symptoms can indicate a retinal detachment, a transient ischemic attack, or a stroke. Prompt evaluation is critical because early treatment may prevent permanent vision loss or other serious complications.
If you have been diagnosed with retinal migraine, regular follow-up appointments with a retina specialist are important. These visits allow your doctor to monitor the health of your retinal blood vessels and check for any subtle changes in your vision. Your retina specialist can also help determine whether your treatment plan needs to be adjusted over time.
Not every episode of temporary vision loss is a migraine. Conditions such as retinal artery occlusion, retinal vein occlusion, and amaurosis fugax (temporary vision loss caused by reduced blood flow) can produce similar symptoms. A retina specialist has the tools and training to differentiate between these conditions and ensure you receive the correct diagnosis and treatment plan.
Questions and Answers
Most ocular migraines resolve without lasting harm. However, retinal migraine, which affects only one eye, involves temporary reduction of blood flow to the retina. In rare cases, repeated episodes have been linked to lasting visual field loss. If you experience recurrent retinal migraines, ongoing monitoring by a retina specialist can help detect any changes early.
The key question is whether the visual change affects one eye or both. Cover one eye at a time to check. If only one eye is involved, if symptoms last longer than 60 minutes, or if this is your first episode, seek evaluation from a retina specialist or emergency room immediately. These features can overlap with a transient ischemic attack or other vascular events that need urgent attention.
Not every episode requires medication. Brief visual disturbances that resolve quickly and are not followed by a severe headache may not need treatment beyond resting in a quiet space. However, if episodes are frequent, disabling, or followed by prolonged headaches, early treatment with NSAIDs or triptans can help. Talk with your retina specialist or neurologist to develop a plan that matches the severity and frequency of your episodes.
Some research has explored the connection between migraine and stroke risk. In a large study of over one million patient charts, ocular migraine was identified in 0.57% of individuals, while stroke was found in 1.40% (ARVO, IOVS Journal). Migraine with aura, in particular, has been associated with a modestly higher cardiovascular risk in some studies. Managing blood pressure, avoiding smoking, and staying physically active are important steps. Discuss your personal risk factors with your healthcare team.
Yes. Ocular migraine can begin as early as age 7, though it is more common to have a first episode in the 20s. Children may have difficulty describing their visual symptoms. If a child reports seeing flashing lights, zig-zag lines, or temporary blind spots, they should be evaluated by an eye care professional. A family history of migraine makes the diagnosis more likely, but other causes of visual disturbance in children should be ruled out.